15 filings · most recent first
APLS 8-K Filings
Apellis Pharmaceuticals Merged With Biogen In 53 Billion Deal
Apellis Pharmaceuticals Amends Executive Separation Plan Ahead Of Merger
Apellis Pharmaceuticals Announces Agreement To Be Acquired By Biogen Inc
Apellis Pharmaceuticals Appoints Mikael Dolsten To Board Of Directors
Apellis Pharmaceuticals Reports Preliminary 2025 Financial Results And Business
Apellis Pharmaceuticals Announces Royalty Buydown Agreement With Sobi
Apellis Pharmaceuticals Annual Meeting Voting Results Announced
Apellis Pharmaceuticals Appoints Craig A Wheeler To Board Of Directors
Apellis Pharmaceuticals Announces Preliminary 2024 Revenues And Key Executive
Apellis Pharmaceuticals Announces Positive Phase 3 Results For Pegcetacoplan In
Apellis Pharmaceuticals Holds Annual Meeting With Director Elections And Audit
Apellis Pharmaceuticals Enters Into 475M Financing Agreement
Apellis Pharmaceuticals Reports Q4 And Fy 2023 Financial Results And Announces
Apellis Pharmaceuticals Appoints New Coo
Apellis Pharmaceuticals Announces Preliminary 2023 Financial Results